A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes

References

• Barbier O, Turgeon D, Girard C, et al. (2000). 3′-Azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Disposition 28:497–502
   PubMed Web of Science ®Google Scholar
• Bosma PJ, Seppen J, Goldhoorn B, et al. (1994). Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960–4
   PubMed Web of Science ®Google Scholar
• Collier AC, Tingle MD, Keelan JA, et al. (2000). A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines. Drug Metab Disposition 28:1184–6
   PubMed Web of Science ®Google Scholar
• Court MH, Duan SX, Guillemette C, et al. (2002). Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTS): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Disposition 30:1257–65
   PubMed Web of Science ®Google Scholar
• Court MH, Zhang X, Ding X, et al. (2012). Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 42:266–77
   PubMed Web of Science ®Google Scholar
• Dean B, Arison B, Chang S, et al. (2004). Identification of UGT2B9*2 and UGT2B33 isolated from female rhesus monkey liver. Arch Biochem Biophys 426:55–62
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. (2001). The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273–97
   PubMed Web of Science ®Google Scholar
• Ghosal A, Hapangama N, Yuan Y, et al. (2004). Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). Drug Metab Disposition 32:267–71
   PubMed Web of Science ®Google Scholar
• Gu J, Zhong D, Chen X. (1999). Analysis of O-glucuronide conjugates in urine by electrospray ion trap mass spectrometry. Fresenius J Anal Chem 365:553–8
   Google Scholar
• Hanioka N, Tanabe N, Jinno H, et al. (2010). Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes. Life Sci 87:261–8
   PubMed Web of Science ®Google Scholar
• Itäaho K, Court MH, Uutela P, et al. (2009). Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10. Drug Metab Disposition 37:768–75
   PubMed Web of Science ®Google Scholar
• Itäaho K, Mackenzie PI, Ikushiro S, et al. (2008). The configuration of the 17-hydroxy group variably influences the glucuronidation of β-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Disposition 36:2307–15
   PubMed Web of Science ®Google Scholar
• Jinno H, Saeki M, Tanaka-Kagawa T, et al. (2003). Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10. Drug Metab Disposition 31:528–32
   PubMed Web of Science ®Google Scholar
• Juvonen RO, Pennanen S, Pasanen M. (1997). A convenient laboratory experiment for teaching the fundamentals of drug metabolism. Am J Pharm Educ 61:314–17
   Web of Science ®Google Scholar
• Krishnaswamy S, Duan SX, Von Moltke LL, et al. (2003). Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Disposition 31:133–9
   PubMed Web of Science ®Google Scholar
• Kurkela M, Garcia-Horsmant JA, Luukkanen L, et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs): UGT1A9 is more resistant to detergent inhibition than the other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536–44
   PubMed Web of Science ®Google Scholar
• Kurkela M, Patana A, Mackenzie PI, et al. (2007). Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genom 17:115–26
   PubMed Web of Science ®Google Scholar
• Kuuranne T, Kurkela M, Thevis M, et al. (2003). Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Disposition 31:1117–24
   PubMed Web of Science ®Google Scholar
• Lang MA, Gielen JE, Nebert DW. (1981). Genetic evidence for many unique liver microsomal P-450-mediated monooxygenase activities in heterogeneic stock mice. J Biol Chem 256:12068–75
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Bock KW, Burchell B, et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677–85
   PubMed Web of Science ®Google Scholar
• Meech R, MacKenzie PI. (2010). UGT3A: novel UDP-glycosyltransferases of the UGT superfamily. Drug Metab Rev 42:43–52
   Web of Science ®Google Scholar
• Miners JO, Mackenzie PI, Knights KM. (2010). The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro--in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev 42:189–201
   Web of Science ®Google Scholar
• Morse MA, Lu J. (1998). High-performance liquid chromatographic method for measurement of cytochrome P450-mediated metabolism of 7-ethoxy-4-trifluoromethylcoumarin. J Chromatogr B Biomed Appl 708:290–3
   Google Scholar
• Ohno S, Nakajin S. (2009). Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Disposition 37:32–40
   PubMed Web of Science ®Google Scholar
• Parkinson A, Ogilvie BW. (2008). Biotransformation of xenobiotics. In: Klaassen CE, ed. Toxicology: the basic science of poisons. 7th ed. New York: McGraw-Hill, 161–304
   Google Scholar
• Price RJ, Surry D, Renwick AB, et al. (2000). CYP isoform induction screening in 96-well plates: Use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytes. Xenobiotica 30:781–95
   PubMed Web of Science ®Google Scholar
• Rahnasto M, Raunio H, Poso A, Juvonen RO. (2003). More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde. Xenobiotica 33:529–39
   PubMed Web of Science ®Google Scholar
• Ritter JK. (2000). Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171–93
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Oellerich M, Wieland E. (2003). Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther Drug Monit 25:1–16
   PubMed Web of Science ®Google Scholar
• Sneitz N, Court MH, Zhang X, et al. (2009). Human UDP-glucuronosyltransferase UGT2A2: CDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3. Pharmacogenet Genom 19:923–34
   PubMed Web of Science ®Google Scholar
• Sridar C, Goosen TC, Kent UM, et al. (2004). Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. Drug Metab Disposition 32:587–94
   PubMed Web of Science ®Google Scholar
• Stresser DM, Blanchard AP, Turner SD, et al. (2000). Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compound's with four fluorometric substrates. Drug Metab Disposition 28:1440–8
   PubMed Web of Science ®Google Scholar
• Testa B, Krämer SD. (2008). The biochemistry of drug metabolism – an introduction: part 4. Reactions of conjugation and their enzymes. Chem Biodivers 5:2171–336
   PubMed Web of Science ®Google Scholar
• Trubetskoy OV, Finel M, Kurkela M, et al. (2007). High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling. Assay Drug Dev Technol 5:343–54
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Ghiciuc C, Opritoui M, et al. (2007). Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica 37:1367–77
   PubMed Web of Science ®Google Scholar
• Zhang H, Tolonen A, Rousu T, et al. (2011). Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells. Drug Metab Disposition 39:456–64
   PubMed Web of Science ®Google Scholar
• Zhong D, Chen X, Gu J, et al. (2001). Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses. Clin Chim Acta 313:147–50
   PubMed Web of Science ®Google Scholar
• Zhu L, Ge G, Zhang H, et al. (2012). Characterization of Hepatic and Intestinal Glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDPGlucuronosyltransferase isoforms. Drug Metabolism and Disposition 40:529–38
   PubMed Web of Science ®Google Scholar